Product Code: RP-ID-10077870 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10077870
Market Overview:
Transplant Diagnostics Market Analysis by Organ Type (Kidney, Liver, Heart, Lung, Pancreas, and Others); by End Users (Hospital, Transplant Centers, Research Laboratories, and Others); and by Application (Diagnostics, and Research)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Global Transplant Diagnostics Market Scope
|
Base Year |
2021 |
|
Forecast Year |
2022-2031 |
|
CAGR |
~7% |
|
Base Year Market Size (2021) |
~ USD 4.0 Billion |
|
Forecast Year Market Size (2031) |
~ USD 8.0 Billion |
Global Transplant Diagnostics Market Size, Forecast, and Trend Highlights Over 2022 - 2031
The global transplant diagnostics market is estimated to garner a revenue of USD 8.0 Billion by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. Further, the market generated a revenue of USD 4.0 Billion in the year 2021. The growth of the market can be attributed to the growing awareness raised by various healthcare facilities about the feasibility of the organ transplant procedure. As per the Global Observatory on Donation and Transplantation, there were 129,681 organs transplanted in 2020.
GET A SAMPLE COPY OF THIS REPORT
Transplant diagnostics refers to tests performed to determine the compatibility of the recipient and donor of an organ prior to or after the transplant. In addition, HLA (human leukocyte antigen) and non-HLA (non-human leukocyte antigen) antibodies tests are the types of transplant diagnostics that are performed prior to organ transplant in order to find the potential donor or to reject incompatible donors. Moreover, they also performed post-organ transplants to check the patient's survival rate. Transplant diagnostics help to improve the success rate of organ transplants by finding the best suitable donor match with the recipient and it is anticipated to surge the market size of the global transplant diagnostics market. As per the Organ Procurement & Transplantation Network, 13681 become deceased organ donors in the United States in the year 2021.
Global Transplant Diagnostics Market: Growth Drivers and Challenges
Growth Drivers
-
Rising Population Across the Globe– With the rising population, the percentage of organ transplants will also increase owing to the presence of a large number of donors and recipients, and it is anticipated to drive the growth of the global transplant diagnostic market. The world population is anticipated to rise by 2 billion people in the next 30 years, showing an increasing trend from 7.7 billion to 9.7 billion in 2050, according to the United Nations.
-
Unhealthy Consumption of Alcohol – Organs can be damaged through long-term heavy alcohol consumption and it is expected to surge the growth of the global transplant diagnostics market. As per the data stated by the World Health Organization in 2022, nearly 3 million people die every year owing to the harmful use of alcohol.
-
Rise in Road Accidents – Approximately 20 and 50 million people across the globe suffer non-fatal injuries, and many of them become disabled as a result of injuries, as per the statistics provided by the World Health Organization.
-
High Prevalence of Chronic and Acute Diseases – People suffering from chronic and acute diseases can affect various organs, causing them to malfunction. According to the Centers for Disease Control and Prevention, more than 50 percent of the total population in the United States has at least one chronic condition, such as failing kidney, cancer, arthritis, lungs problem, and others.
-
Increasing Incidence of Deaths– There has been an increasing need for organ transplants that raises the demand for transplant diagnostics and the non-availability of matched donors and recipients causes deaths. According to the Health Resources & Services Administration, 17 people die every day owing to the non-availability of organs for transplant.
Challenges
-
Risks and Complexities Involved in Transplant Procedures
-
Expensive Transplant Diagnostics Procedures
-
Extensive Difference Between the Rising Demand and Unequalled Supply of Organs
The global transplant diagnostics market is segmented and analyzed for demand and supply by organ type into kidney, liver, heart, lung, pancreas, and others. The kidney segment is expected to hold the largest share of the market size and is anticipated to witness steady growth over the forecast period, on the back of factors such as the rising demand for kidney transplant surgeries and various actions undertaken by the government to meet the demand for organ transplantation. Approximately 90,000 people are waiting for a donor kidney in the United States. Moreover, every 10 minutes a person is added to the transplant waiting list.
Global Transplant Diagnostics Market Regional Synopsis
Regionally, the global transplant diagnostics market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2031. This can be attributed to the strong healthcare facilities in the region followed by the high investment made by the North American government in accumulating advanced diagnostic tools. Furthermore, the considerable actions taken by the North American government to reimburse policies and asserting high expenditure on surgeries along with the availability of specialized professionals are among the many factors that are expected to drive the growth of the transplant diagnostics market in the region. According to the Health Resources and Services Administration, more than 40,000 transplants were performed in 2021, and approximately 106,106 children, men, and women are on the transplant waiting list with nearly 17 people dying each day, as the recipients for organ transplantation are higher than the donors in the United States.
However, the market in the Asia Pacific region is also projected to witness considerable growth owing to an increase in the attention given to healthcare facilities, advancements in technology, and the increase in the prevalence of chronic diseases.
Market Segmentation
Our in-depth analysis of the global transplant diagnostics market includes the following segments:
|
By Organ Type |
|
|
By End Users |
|
|
By Application |
|
Key Companies Dominating the Global Transplant Diagnostics Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global transplant diagnostics market that are included in our report are Immucor, Inc., Biocartis NV, Becton, Dickinson and Company, Illumina, Inc., 4SR Biosciences Inc., Thermo Fisher Scientific Inc., CareDx, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Hologic, Inc., and others.
Global Transplant Diagnostics Market: Latest Developments
-
May, 2022: Illumina, Inc., accelerator invested in seven Omics start-ups, advancing through therapeutics, diagnostics, DNA storage, mental wellness, and sustainable foods applications.
-
4 March 2022: Immucor, Inc., announced the launch of their innovation in transplant diagnostics, MIA FORA NGS MFlex HLA Typing Software which would serve as a cost-saving option for a standard windows desktop computing system.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Immucor Inc.
- Biocartis NV
- Becton
- Dickinson and Company
- Illumina Inc.
- 4SR Biosciences Inc.
- Thermo Fisher Scientific Inc.
- CareDx, Inc.
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Hologic, Inc
Related Reports
Proof of Quality & Reliability
